Paper Review Records
All Paper Review Records
17 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
The positive allosteric modulator of the GABA B receptor, ASP8062, attenuates alcohol self-administration in female Sardinian alcohol-preferring rats
Paola Maccioni; Mauro A. M. Carai; Federico Corelli; Giancarlo ColomboShow moreShow less
1. Neuroscience Institute, Section of Cagliari, National Research Council of Italy, Monserrato, Italy; 2. Cagliari Pharmacological Research, Cagliari, Italy; 3. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, ItalyShow moreShow less
Controlling the uncontrollable? navigating naturalistic and controlled dosing in cannabis research
Samantha N. Melendez; Margy Y. Chen; Claire L. Pince; L. Cinnamon Bidwell; Angela D. BryanShow moreShow less
1. Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, USA; 2. Institute of Cognitive Science, University of Colorado Boulder, Boulder, USAShow moreShow less
Evaluating whether a therapeutic dose of ketamine exposure during adolescence influences adult vulnerability in rats to commonly abused drugs
Jordi Jornet-Plaza; Carles Colom-Rocha; M. Julia García-FusterShow moreShow less
1. IUNICS, University of the Balearic Islands, Palma, Spain; 2. Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain; 3. Department of Medicine, University of the Balearic Islands, Palma, Spain; 4. Red de Investigación en Atención Primaria en Adicciones (RIAPAd), ISCIII, Madrid, Spain; 5. Beato Luis Belda University College, Universidad San Pablo-CEU, CEU Universities, Palma, SpainShow moreShow less
Sex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis
Aline Frick; Grace Blest-Hopley; Manesh Girn; David Erritzoe; David Nutt; Robin Carhart-HarrisShow moreShow less
1. Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands; 2. University of Zürich, Zürich, Switzerland; 3. Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 4. Department of Neurology, University of California San Francisco, San Francisco, USA; 5. Carhart-Harris Lab, Department of Neurology, University of California San Francisco, San Francisco, USA; 6. Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UKShow moreShow less
Subjective alcohol response across drinking contexts: a systematic review with bayesian meta-analysis
Karla Kovacek; Carolyn Zhu; Vidhi Patel; Cheyenne Morris; Jesus ChavarriaShow moreShow less
1. Department of Psychology, Western University, London, CanadaShow moreShow less
Is it safe—and ethical—to prescribe THC to youth?
José Alexandre S. Crippa; Jaime E. C. HallakShow moreShow less
1. Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; 2. Laboratory of Psychiatric Neuroimaging (LIM21), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil; 3. Neuroscience and Behavior Department, Faculty of Medicine of Ribeirão Preto, University of São Paulo (Address) Hospital das Clínicas - Terceiro Andar, Ribeirão Preto, São Paulo, BrasilShow moreShow less
FAQ
How long does PSYCHOPHARMACOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 17 complete review records for PSYCHOPHARMACOLOGY. The fastest paper went from submission to acceptance in 83 days (Evaluating whether a therapeutic dose of ketamine exposure during adolescence influences adult vulnerability in rats to commonly abused drugs, received 2026-07-28, accepted 2026-10-19); the slowest took 315 days. The average is 156.4 days and the median is 125 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
